ClinVar database of global familial hypercholesterolemia‐associated DNA variants
Open Access
- 11 October 2018
- journal article
- research article
- Published by Wiley in Human Mutation
- Vol. 39 (11) , 1631-1640
Abstract
Accurate and consistent variant classification is imperative for incorporation of rapidly developing sequencing technologies into genomic medicine for improved patient care. An essential requirement for achieving standardized and reliable variant interpretation is data sharing, facilitated by a centralized open‐source database. Familial hypercholesterolemia (FH) is an exemplar of the utility of such a resource: it has a high incidence, a favorable prognosis with early intervention and treatment, and cascade screening can be offered to families if a causative variant is identified. ClinVar, an NCBI‐funded resource, has become the primary repository for clinically relevant variants in Mendelian disease, including FH. Here, we present the concerted efforts made by the Clinical Genome Resource, through the FH Variant Curation Expert Panel and global FH community, to increase submission of FH‐associated variants into ClinVar. Variant‐level data was categorized by submitter, variant characteristics, classification method, and available supporting data. To further reform interpretation of FH‐associated variants, areas for improvement in variant submissions were identified; these include a need for more detailed submissions and submission of supporting variant‐level data, both retrospectively and prospectively. Collaborating to provide thorough, reliable evidence‐based variant interpretation will ultimately improve the care of FH patients.Keywords
Funding Information
- National Human Genome Research Institute (U41HG006834, U41HG009649, U41HG009650, U01HG007436, U01HG007437)
- Fundação para a Ciência e a Tecnologia (SFRH/BD/108503/2015)
- Ministerstvo Zdravotnictví Ceské Republiky (16–29084A, 15–28277A)
- British Heart Foundation (BHF PG08/008)
- National Institute for Health Research
- University College London Hospitals NHS Foundation Trust
This publication has 19 references indexed in Scilit:
- Analysis of publicly available LDLR, APOB, and PCSK9 variants associated with familial hypercholesterolemia: application of ACMG guidelines and implications for familial hypercholesterolemia diagnosisGenetics in Medicine, 2018
- Clinically impactful differences in variant interpretation between clinicians and testing laboratories: a single-center experienceGenetics in Medicine, 2018
- Familial hypercholesterolaemiaNature Reviews Disease Primers, 2017
- Sherloc: a comprehensive refinement of the ACMG–AMP variant classification criteriaGenetics in Medicine, 2017
- Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysisBMJ Open, 2017
- Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe HypercholesterolemiaJACC, 2016
- Using ClinVar as a Resource to Support Variant InterpretationCurrent Protocols in Human Genetics, 2016
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Actionable exomic incidental findings in 6503 participants: challenges of variant classificationGenome Research, 2015
- Multiple crm- mutations in familial hypercholesterolemia. Evidence for 13 alleles, including four deletions.Journal of Clinical Investigation, 1988